Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Amanda, Nicoll"'
Autor:
Alan Wigg, Jonathan Tibballs, Richard Woodman, Katherine Stuart, Hien Le, Stuart K. Roberts, John K. Olynyk, Simone I. Strasser, Michael Wallace, Jarad Martin, Annette Haworth, Nicholas Hardcastle, Kee Fong Loo, Colin Tang, Yoo Young Lee, Julie Chu, Richard De Abreu Lourenco, Adam Koukourou, Diederick De Boo, Kate McLean, Jackie Buck, Rohit Sawhney, Amanda Nicoll, Anouk Dev, Marnie Wood, Alicia Braund, Martin Weltman, Richard Khor, Miriam Levy, Tim Wang, Michael Potter, James Haridy, Ashok Raj, Oliver Duncan, Amany Zekry, Natalie Collier, James O’Beirne, Catherine Holliday, Yuvnik Trada, Jaw Tronidjaja, Jacob George, David Pryor
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Therapeutic options for early-stage hepatocellular carcinoma (HCC) in individual patients can be limited by tumor and location, liver dysfunction and comorbidities. Many patients with early-stage HCC do not receive curative-intent
Externí odkaz:
https://doaj.org/article/6d523d1c82814f78b6224ff1b323717f
Autor:
Paul J. Clark, Patricia C. Valery, James Ward, Simone I. Strasser, Martin Weltman, Alexander Thompson, Miriam T. Levy, Barbara Leggett, Amany Zekry, Julian Rong, Peter Angus, Jacob George, Steven Bollipo, Bruce McGarity, William Sievert, Gerry Macquillan, Edmund Tse, Amanda Nicoll, Amanda Wade, Geoff Chu, Damian Harding, Wendy Cheng, Geoff Farrell, Stuart K. Roberts
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background First Nations Peoples of Australia are disproportionally affected by hepatitis C (HCV) infection. Through a prospective study we evaluated the outcome of direct-acting antiviral (DAA) therapy among First Nations Peoples with HCV i
Externí odkaz:
https://doaj.org/article/c756cff2c64949afbd083b0f41c57a38
Autor:
Gauri Mishra, Anouk Dev, Eldho Paul, Wa Cheung, Jim Koukounaras, Ashu Jhamb, Ben Marginson, Beng Ghee Lim, Paul Simkin, Adina Borsaru, James Burnes, Mark Goodwin, Vivek Ramachandra, Manfred Spanger, John Lubel, Paul Gow, Siddharth Sood, Alexander Thompson, Marno Ryan, Amanda Nicoll, Sally Bell, Ammar Majeed, William Kemp, Stuart K. Roberts, The Melbourne Liver Group
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Repeat transarterial chemoembolisation (rTACE) is often required for hepatocellular carcinoma (HCC) to achieve disease control, however, current practice guidelines regarding treatment allocation vary significantly. This study aim
Externí odkaz:
https://doaj.org/article/da3bca8a76f94edcac7a72e2d08cd0cf
Autor:
Paul J. Clark, Patricia C. Valery, Simone I. Strasser, Martin Weltman, Alexander J. Thompson, Miriam Levy, Barbara Leggett, Amany Zekry, Julian Rong, Peter Angus, Jacob George, Steven Bollipo, Bruce McGarity, William Sievert, Gerry Macquillan, Edmund Tse, Amanda Nicoll, Amanda Wade, Geoff Chu, Damian Harding, Wendy Cheng, Geoff Farrell, Stuart K. Roberts
Publikováno v:
Digestive Diseases and Sciences. 68:291-303
In 2016, direct-acting antiviral (DAA) treatment for hepatitis C (HCV) became available through Australia's universal health care system, with the aim of HCV elimination. We report real-world effectiveness of DAA HCV treatment in Australia from a cli
Autor:
Natasha Janko, Ammar Majeed, Warren Clements, Michael A. Fink, John Lubel, Mark Goodwin, Amanda Nicoll, Simone I. Strasser, Siddharth Sood, Steven Bollipo, John Bate, Kaye A Bowers, Jacob George, William Kemp, Stuart K. Roberts
Publikováno v:
Hepatology Communications. 7
Autor:
Alan Wigg, Sally Watkinson, Mark Wilson, Amanda Nicoll, Edmund Tse, Kate Muller, Guru Iyngkaran, Geoff Hebbard, Joe Sasadeusz, Danny Liew, Jeffrey Stewart, Emma Tilley, Anton Colman, James Haridy, Rosalie Altus, Stephen Bloom, Renjy Nelson, Jeyamani Ramachandran
Publikováno v:
Internal Medicine Journal. 51:1927-1934
Background & aims A unique model of care was adopted in Australia following introduction of universal subsidised direct-acting antiviral (DAA) access in 2016 in order to encourage rapid scale-up of treatment. Community-based medical practitioners and
Autor:
Karl Vaz, Numan Kutaiba, Paul J Gow, Niranjan Arachchi, Anouk Dev, Ammar Majeed, Michael A Fink, Sarah Gardner, Marie Sinclair, Stuart K. Roberts, Kurvi Patwala, Amanda Nicoll, Sally Bell, John S Lubel, Ning Mao Kam, Adam G Testro, Anh Duy Pham, Gauri Mishra, Peter W Angus, Siddharth Sood, Zaid S. Ardalan, Ross Apostolov, William Kemp
Publikováno v:
World Journal of Hepatology
Background Management of single small hepatocellular carcinoma (HCC) is straightforward with curative outcomes achieved by locoregional therapy or resection. Liver transplantation is often considered for multiple small or single large HCC. Management
Autor:
William Kemp, Wendy Cheng, Katherine A. Stuart, Lauren Beswick, Amanda Nicoll, Richard Skoien, Siddharth Sood, Daniel Croagh, Hugh Gao, Andrew J. Metz, Ammar Majeed, Marie Sinclair, Eric Y. Lee, Avik Majumdar, Alexander J. Thompson, Simon Edmunds, Joanne Mitchell, Stuart K. Roberts, Nicholas Shackel, Kate Muller, Neomal S. Sandanayake, Alicia Braund, Martin Weltman, Philip I. Craig, Gerry MacQuillan, Edmund Tse, Stephen M. Riordan, Anouk Dev
Publikováno v:
Liver International. 41:2934-2943
BACKGROUND AND AIMS: IgG4 sclerosing cholangitis (IgG4-SC) is the biliary component of the multisystem IgG4-related disease. We aimed to investigate the clinical features, demographics, treatment response and outcomes of IgG4-SC in a large Australian
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:38-85
Background and Aim: Drug-induced liver injury (DILI) can involve serious adverse reactions to many drug classes, causing a wide clinical and biochemical spectrum of liver injury. Despite a rise in prevalence and it being the most common cause of acut
Autor:
Kurvi Patwala, David Stephen Prince, Yael Celermajer, Waafiqa Alam, Eldho Paul, Simone Irene Strasser, Geoffrey William McCaughan, Paul Gow, Siddharth Sood, Elise Murphy, Stuart Roberts, Elliot Freeman, Elizabeth Stratton, Scott Anthony Davison, Miriam Tania Levy, McCawley Clark-Dickson, Vi Nguyen, Sally Bell, Amanda Nicoll, Ashley Bloom, Alice Unah Lee, Marno Ryan, Jessica Howell, Zina Valaydon, Alexandra Mack, Ken Liu, Anouk Dev
Introduction: Hepatocellular carcinoma (HCC) is a serious complication of chronic liver disease. Lenvatinib is an oral multikinase inhibitor registered to treat advanced HCC. This study evaluates the real-world experience with lenvatinib in Australia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8eddc759ea93d1633fa8a0411d33cea
https://doi.org/10.21203/rs.3.rs-1714922/v1
https://doi.org/10.21203/rs.3.rs-1714922/v1